Enter inventor name

EPO Patents = 4

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 176(Granted Patents)

Location History:

Hofheim, DE (1996)
Hofheim am Taunus, DE (1993 - 1997)
Hofheim/Ts., DE (1995 - 1997)
Frankfurt-am-Main, DE (2011 - 2013)
Mainz-Kastel, DE (1998 - 2014)

Company Filing History:

12 out of 6,662

Hoechst Aktiengesellschaft

patents

12 out of 330

Aventis Pharma Deutschland, Gmbh

patents

5 out of 1,829

Sanofi-a Ventis Deutschland Gmbh

patents

4. 1 out of 18

Hoechst Marion Roussel Deutschland Gmbh

8. 1 out of 832,843

Other

patents

Years Active: 1993-2014

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8710232 - Imidazole derivatives used as TAFIa inhibitors (2014-04-29),

2. 8586612 - Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them (2013-11-19),

3. 8501981 - CXCR2 inhibitors (2013-08-06),

4. 8283479 - CXCR2 inhibitors (2012-10-09),

5. 8044208 - Imidazole derivatives as inhibitors of TAFIa (2011-10-25),

6. 7919628 - CXCR2 inhibitors (2011-04-05),

7. 7550257 - Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels (2009-06-23),

8. 6984660 - P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparation and use (2006-01-10),

9. 6979532 - Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels (2005-12-27),

10. 6538144 - P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparation and use (2003-03-25),

11. 6511989 - Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them (2003-01-28),

12. 6472413 - Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them (2002-10-29),

13. 6462024 - Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart (2002-10-08),

14. 6429222 - 1-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical preparations comprising them (2002-08-06),

15. 6414030 - Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptors blockers (2002-07-02),

Title: Holger Heitsch - Innovative Inventor from Mainz-Kastel

Introduction: Holger Heitsch is a renowned inventor hailing from Mainz-Kastel, Germany, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Holger Heitsch holds several patents in the areas of renewable energy, sustainable materials, and advanced manufacturing processes, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Holger Heitsch has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Holger Heitsch has collaborated with top engineers, scientists, and designers to bring his innovative ideas to life, resulting in successful products and solutions that have had a lasting impact on society.

Conclusion: Holger Heitsch's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, solidifying his legacy as a true pioneer in the world of technology and invention.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com